Tabil, Meca Yla .
HRN: 00-97-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2026
CEFUROXIME 1.5GM (VIAL)
01/07/2026
01/14/2026
IVT
1.5g
Q8
CAP Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes